Stay updated with breaking news from Gyo Sagara. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Japan's Ono Pharmaceutical Co said on Tuesday its $2.4 billion takeover of Deciphera Pharmaceuticals is a first step in expanding in U.S. and European markets. WHY IT'S...
By Rocky Swift TOKYO (Reuters) - Japan's Ono Pharmaceutical Co said on Tuesday its $2.4 billion takeover of Deciphera Pharmaceuticals is a "first step" in expanding in U.S. and European markets. WHY IT'S IMPORTANT With this deal, Ono Pharma joins J...
Deciphera Shareholders to Receive $25.60 per Share in Cash Deciphera’s Kinase Inhibitor Expertise and Established Commercialization Platform in Key Markets Will Reinforce ONO Pharmaceutical’s...
Ono Pharmaceutical will pay $25.60 per Deciphera share in cash, a premium of nearly 75 percent on the Waltham cancer biotech’s closing price of $14.65 on Friday.